Mice treated with anti-CD4 monoclonal antibody accept fully allogeneic thyroid grafts but reject second-donor-type thyroid grafts in maintenance phase.
Niimi
M
M
Department of Surgery, Teikyo University, Tokyo, Japan.
Takashina
M
M
Ikeda
Y
Y
Shirasugi
N
N
Shatari
T
T
Takami
H
H
Kodaira
S
S
Kameyama
K
K
Matsumoto
K
K
Hamano
K
K
Esato
K
K
D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D015704:CD4 Antigens / Q000276:immunology*; D006084:Graft Rejection / Q000276:immunology*; D006085:Graft Survival / Q000276:immunology*; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000494:pharmacology; D051379:Mice; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA; D013370:Subrenal Capsule Assay; D013961:Thyroid Gland / Q000473:pathology / Q000637:transplantation*; D014184:Transplantation, Homologous / Q000276:immunology* / Q000473:pathology
D000911:Antibodies, Monoclonal; D015704:CD4 Antigens; D007166:Immunosuppressive Agents